Effects of tDCS on High Level and Recreational Athletes

Healthy Clinical Trial

Official title:

Comparing the Effects of tDCS on Endurance Parameters Between High Level and Recreational Athletes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03893604
• Other study ID #: 2017-313
• Status: Completed
• Phase: N/A
• Start date: March 31, 2019
• Est. completion date: June 30, 2019

Study information

• Verified date: March 2020
• Source: University of Liege
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Healthy recreational and high level athletes will undergo 2 randomized, cross-over counterbalanced sessions of anodal tDCS or sham tDCS.

The primary outcome is an isokinetic evaluation of their hamstrings' and quadriceps' endurance after each session

Description:

Recruitment :

Healthy recreational and high level athletes will be recruited through social media and advertisements.

Each subject came twice to the Liege University Hospitals' isokinetic lab. Each session began with strapping the subjet into the isokinetic machine, making sure that all the settings were adapted to the subject. Then, each subject received either anodal tDCS, of sham tDCS. Neither the evaluator or the subject knew which they were receiving. Immediately following tDCS, there was a warmup consisting of stationary bike, and an isokinetic warmup. Then, subjects' endurance was using a maximal isokinetic tests, at 30 maximal concentric and eccentric contractions at a speed of 180°/s.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: June 30, 2019
• Est. primary completion date: June 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• For the "recreational" group at most 3 hours of sport a week

• For the "athletic" group, at least 10 hours of sport a week

• Right handed and footed

Exclusion Criteria:

• One on the TSST (in high and relatively high risk sections)

• Previous neurological or orthopedic pathologies affecting limbs

Related Conditions & MeSH terms

• Athlete
• Healthy

Intervention

Device:
• tDCS
20 minutes of anodal tDCS (C3/FP2) 2mA or sham

Locations

Country	Name	City	State
Belgium	Liege Univeristy Hospital	Liege

Sponsors (1)

Lead Sponsor	Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Peak Strength	Peak strength (measured by the isokinetic machine) is measured after each of the 30 repetitions.; Peak strength of the 30 repetitions will be measured, and how strength decreases throughout the test will be analysed	Immediately after tDCS and sham